215 related articles for article (PubMed ID: 37632526)
1. Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.
Patel N; Keating G; Solanki GA; Syed HR; Keating RF
Childs Nerv Syst; 2023 Oct; 39(10):2633-2647. PubMed ID: 37632526
[TBL] [Abstract][Full Text] [Related]
2. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
3. Brain and Spinal Cord Tumors of Embryonic Origin.
Lampros M; Alexiou GA
Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
[TBL] [Abstract][Full Text] [Related]
4. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
5. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
6. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
7. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.
Rosenberg T; Cooney T
Pediatr Neurosurg; 2023; 58(5):299-306. PubMed ID: 37245504
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
11. Molecular correlates of cerebellar mutism syndrome in medulloblastoma.
Jabarkheel R; Amayiri N; Yecies D; Huang Y; Toescu S; Nobre L; Mabbott DJ; Sudhakar SV; Malik P; Laughlin S; Swaidan M; Al Hussaini M; Musharbash A; Chacko G; Mathew LG; Fisher PG; Hargrave D; Bartels U; Tabori U; Pfister SM; Aquilina K; Taylor MD; Grant GA; Bouffet E; Mankad K; Yeom KW; Ramaswamy V
Neuro Oncol; 2020 Feb; 22(2):290-297. PubMed ID: 31504816
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
[TBL] [Abstract][Full Text] [Related]
13. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
Shih RY; Koeller KK
Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
[TBL] [Abstract][Full Text] [Related]
14. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
[TBL] [Abstract][Full Text] [Related]
15. Prediction of central nervous system embryonal tumour outcome based on gene expression.
Pomeroy SL; Tamayo P; Gaasenbeek M; Sturla LM; Angelo M; McLaughlin ME; Kim JY; Goumnerova LC; Black PM; Lau C; Allen JC; Zagzag D; Olson JM; Curran T; Wetmore C; Biegel JA; Poggio T; Mukherjee S; Rifkin R; Califano A; Stolovitzky G; Louis DN; Mesirov JP; Lander ES; Golub TR
Nature; 2002 Jan; 415(6870):436-42. PubMed ID: 11807556
[TBL] [Abstract][Full Text] [Related]
16. [Germ cell and embryonal tumors].
Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
Malbari F; Gill J; Daigle A; Rodriguez LL; Raghubar KP; Davis KC; Scheurer M; Ma MM; Kralik SF; Meoded A; Okcu MF; Chintagumpala MM; Aldave G; Weiner HL; Kahalley LS
Pediatr Neurol; 2022 Jul; 132():4-10. PubMed ID: 35598587
[TBL] [Abstract][Full Text] [Related]
18. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of CNS embryonal tumors.
Momota H; Holland EC
Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
